CHARGEPOINT HOLDINGS INC (CHPT)

US15961R1059 - Common Stock

1.16  +0.03 (+2.65%)

After market: 1.15 -0.01 (-0.86%)

Fundamental Rating

2

Taking everything into account, CHPT scores 2 out of 10 in our fundamental rating. CHPT was compared to 88 industry peers in the Electrical Equipment industry. CHPT may be in some trouble as it scores bad on both profitability and health. CHPT is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year CHPT has reported negative net income.
In the past year CHPT has reported a negative cash flow from operations.
In the past 5 years CHPT always reported negative net income.
In the past 5 years CHPT always reported negative operating cash flow.

1.2 Ratios

CHPT's Return On Assets of -39.22% is on the low side compared to the rest of the industry. CHPT is outperformed by 67.05% of its industry peers.
Looking at the Return On Equity, with a value of -170.49%, CHPT is doing worse than 73.86% of the companies in the same industry.
Industry RankSector Rank
ROA -39.22%
ROE -170.49%
ROIC N/A
ROA(3y)-36.12%
ROA(5y)-52.04%
ROE(3y)-97.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CHPT's Gross Margin of 20.30% is in line compared to the rest of the industry. CHPT outperforms 47.73% of its industry peers.
CHPT's Gross Margin has been stable in the last couple of years.
CHPT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-1.39%

2

2. Health

2.1 Basic Checks

CHPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CHPT has more shares outstanding
Compared to 5 years ago, CHPT has more shares outstanding
CHPT has a better debt/assets ratio than last year.

2.2 Solvency

CHPT has an Altman-Z score of -2.27. This is a bad value and indicates that CHPT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.27, CHPT is doing worse than 77.27% of the companies in the same industry.
CHPT has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
CHPT's Debt to Equity ratio of 1.24 is on the low side compared to the rest of the industry. CHPT is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF N/A
Altman-Z -2.27
ROIC/WACCN/A
WACC8.95%

2.3 Liquidity

A Current Ratio of 2.03 indicates that CHPT has no problem at all paying its short term obligations.
CHPT has a Current ratio (2.03) which is comparable to the rest of the industry.
CHPT has a Quick Ratio of 1.32. This is a normal value and indicates that CHPT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.32, CHPT perfoms like the industry average, outperforming 48.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.32

6

3. Growth

3.1 Past

CHPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.50%, which is quite impressive.
CHPT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.23%.
Measured over the past years, CHPT shows a very strong growth in Revenue. The Revenue has been growing by 40.66% on average per year.
EPS 1Y (TTM)47.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y51.22%
Revenue growth 5Y40.66%
Sales Q2Q%-9.68%

3.2 Future

CHPT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.04% yearly.
Based on estimates for the next years, CHPT will show a quite strong growth in Revenue. The Revenue will grow by 15.29% on average per year.
EPS Next Y50.52%
EPS Next 2Y32.14%
EPS Next 3Y23.78%
EPS Next 5Y36.04%
Revenue Next Year-19.7%
Revenue Next 2Y-1.35%
Revenue Next 3Y9.12%
Revenue Next 5Y15.29%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHPT. In the last year negative earnings were reported.
Also next year CHPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CHPT's earnings are expected to grow with 23.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.14%
EPS Next 3Y23.78%

0

5. Dividend

5.1 Amount

CHPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHARGEPOINT HOLDINGS INC

NYSE:CHPT (12/17/2024, 8:49:56 PM)

After market: 1.15 -0.01 (-0.86%)

1.16

+0.03 (+2.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap511.56M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.22%
ROE -170.49%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 20.3%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.03
Quick Ratio 1.32
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)47.5%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y50.52%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.23%
Revenue growth 3Y51.22%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y